Liposomal and acetylated forms bypass this degradation, achieving 6080% bioavailability, which is why clinical protocols specify these formulations rather than generic reduced glutathione tablets
The company received FDA Fast Track designation to investigate the drug for moderate-to-severe OSA in patients with obesity in 2022
Nutrients, 14 (17), 3459
Trial results vary by drug, dose, baseline weight, adherence, side-effect tolerance, and whether patients can stay on treatment
Similarly, data in advanced liver disease are sparse
However, keep in mind that, just like Ozempic, there is a shortage of many of these medications, meaning that individuals with a medical need for these drugs should be getting them first